Fig. 2From: Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trialKaplan–Meier curves for a disease-free survival relative to treatment arm and Kaplan–Meier curves for b overall survival relative to treatment armBack to article page